< Back to all clusters
[HEALTH] · Iran · 10 sources

started · updated

Iran begins influenza vaccine distribution amid medication crisis

Iran has begun the distribution of influenza vaccines following delays in securing supplies from European manufacturers. The Food and Drug Administration (FDA) has announced a plan to supply a total of 2.8 million doses, sourcing vaccines from Russia and China. In the first phase, approximately 700,000 doses have been distributed, with 350,000 allocated to the national health network and 350,000 to pharmacies.

Official sources have issued warnings regarding a black market for vaccines. Unapproved influenza vaccines are reportedly being sold for between 10 and 15 million Tomans. Health officials and the Iranian Pharmacists Association cautioned that these unauthorized products may not meet safety, efficacy, or cold-chain storage standards. The approved price for vaccines in pharmacies is set at 2,185,000 Tomans.

The vaccine rollout occurs amidst a broader medication crisis in Iran. The FDA reported that average medicine prices have risen by approximately 103 percent since the beginning of the current year, while out-of-pocket patient costs have increased by 35 percent. These rising costs are attributed to a $900 million reduction in preferential foreign-currency allocations for medical supplies, alongside increased production and import costs.

Entities

China · Food and Drug Administration · Food and Drug Organization of Iran · Hadi Ahmadi · Iran · Iran Food and Drug Administration · Iran Pharmacists Association · Iranian Pharmacists Association · Majlis · Russia · Sinopharm

Claims

What the coverage asserts, and how many sources carry each claim.